innovation for industry
Articles ＆ files | Focus | Article
PEPS enables large scale clinical testing using MS-based proteomics, and in the future, the discovery of new biomarkers.
PEPS is a highly reliable and robust microfluidic device that rapidly processes whole blood samples at the patient’s bedside, enabling point-of-need and standardized MS-based proteomics analyses.
This technology is under evaluation for different application
by industrial partners.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.